Latest Mental Health News

Page 6 of 13
Doctor Care Anywhere has reported its first profitable year, driven by a 6.5% revenue growth and improved margins, setting the stage for accelerated growth in 2026. The telehealth provider reaffirms ambitious medium-term targets amid operational enhancements and new clinical pathways.
Ada Torres
Ada Torres
25 Feb 2026
TrivarX Limited reported a $1.26 million half-year loss as it completed the acquisition of Stabl-Im brain imaging IP and validated its mental health screening technology in veterans. The company raised $4.2 million to fund clinical development and expand its diagnostic portfolio.
Ada Torres
Ada Torres
24 Feb 2026
Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.
Ada Torres
Ada Torres
17 Feb 2026
Emyria has secured expanded funding from Medibank to support its Treatment-Resistant Depression and PTSD programs at a new clinic in Victoria, marking a significant step in its national mental health care rollout.
Ada Torres
Ada Torres
16 Feb 2026
Dataworks Group Limited has reached a significant milestone, turning cash flow positive in the second quarter of FY26, supported by over $30 million in secured government contracts and a robust global pipeline for its centralised self-exclusion technology.
Sophie Babbage
Sophie Babbage
16 Feb 2026
Future Generation Global Limited has announced a substantial 49% increase in its fully franked dividend for FY2025, alongside a special dividend, reflecting robust portfolio performance and a commitment to shareholder returns.
Claire Turing
Claire Turing
9 Feb 2026
Emyria Limited reports that approximately 67% of patients treated for PTSD remain in remission over 12 months post-treatment, highlighting the potential for lasting recovery and cost-effective care.
Ada Torres
Ada Torres
2 Feb 2026
Entropy Neurodynamics has successfully enrolled and dosed the first patient in its pioneering clinical trial of TRP-8803, an intravenous psilocin formulation targeting Binge Eating Disorder, while securing $6.1 million in new funding to accelerate development.
Ada Torres
Ada Torres
30 Jan 2026
TrivarX Limited has expanded its diagnostic portfolio by acquiring the Stabl-Im brain cancer imaging technology and reported strong clinical trial results validating its single-lead ECG algorithm for depression screening in US veterans.
Ada Torres
Ada Torres
30 Jan 2026
Image Resources NL reported a strong finish to 2025 with record heavy mineral concentrate production and sales, alongside promising developments in its gold exploration and synthetic rutile innovation.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Doctor Care Anywhere reported steady consultation growth and a third consecutive quarter of positive cashflow in Q4 2025, while advancing digital health pilots and reaffirming ambitious medium-term revenue and profitability goals.
Ada Torres
Ada Torres
29 Jan 2026
Emyria Limited has reported strong quarterly revenue growth driven by the expansion of its Empax clinic network across multiple Australian states, supported by a recent $8 million institutional placement to fund its national rollout and workforce expansion.
Ada Torres
Ada Torres
28 Jan 2026

Browse the archive

Full archive